Kathy Nielsen

CEO

Kathy brings over 25 years of experience in senior leadership and advisory roles primarily in the life science sector, with deep experience in technology transfer (IP, licensing, partnerships), venture capital, creating and advancing spin out companies, and operating in the nexus between research and the pharmaceutical industry.

Kathy joins BioCurate from Monash Innovation (Senior Director Commercialisation), having led the growing Commercialisation team, and managed a large and dynamic portfolio of early stage assets. She has had a strong transaction focus, brokering numerous deals with major pharmaceutical companies, as well creating more than 25 Monash spin offs for the development of new therapeutics, many of which have secured multi-million dollar investments. She has strong corporate governance experience, having held 17 Directorships and 5 Observer positions.

Previously, Kathy was Senior Investment Manager at Queensland Investment Corporation, which managed several funds both in Australia and USA, investing in more than 20 biotech/life science companies and generating significant returns for Australian investors. Kathy has also held senior roles in technology transfer at the University of Queensland and a number of its spin out companies. Kathy has also made substantial non-commercial impacts during her career, including through her role as Director, Research & Advocacy at Ovarian Cancer Australia. She was crucial in developing a National Action Plan for high impact research and to inform, engage and amplify the voices of women with ovarian cancer, through consumer-driven research.